SNGX Financials | Income, Balance Sheet & Cash Flow
The financial statements for SNGX (SNGX) provide a snapshot of revenue trends, balance-sheet strength, and cash flow quality. Reviewing these together helps investors evaluate earnings durability, capital structure, and whether operating cash flow supports long-term business growth.
See stock fair value and complete historical financials—premium unlocks deeper tables and metrics.
Financial Statements
Related peers
Compare More →| XBIO Xenetic Biosciences, Inc. | $3.49 +3.25% |
| KZIA Kazia Therapeutics Limited | $10.92 +9.20% |
| TTNP Titan Pharmaceuticals, Inc. | $2.34 -11.36% |
| ENSC Ensysce Biosciences, Inc. | $0.52 -2.60% |
| QLGN Qualigen Therapeutics, Inc. | $3.21 +5.59% |
| SILO Silo Pharma, Inc. | $0.51 +24.30% |
| Peer | Price | Change | Market Cap | PE | EPS | Div Yield (TTM) | Analyst Rating | Volume |
|---|---|---|---|---|---|---|---|---|
| XBIO Xenetic Biosciences, Inc. | $3.49 | +3.25% | 5.94 M | -2.21 | -1.58 | 0.00% | Hold | 33 |
| KZIA Kazia Therapeutics Limited | $10.92 | +9.20% | 17.69 M | -1.45 | -7.52 | 0.00% | Buy | 283 |
| TTNP Titan Pharmaceuticals, Inc. | $2.34 | -11.36% | 3.11 M | -0.80 | -2.92 | 0.00% | Hold | 132 |
| ENSC Ensysce Biosciences, Inc. | $0.52 | -2.60% | 4.84 M | -0.13 | -3.98 | 0.00% | Hold | 205 |
| QLGN Qualigen Therapeutics, Inc. | $3.21 | +5.59% | 5.43 M | 1.13 | 2.85 | 0.00% | Buy | 369 |
| SILO Silo Pharma, Inc. | $0.51 | +24.30% | 4.08 M | -1.02 | -0.50 | 0.00% | Buy | 3.53 |
Frequently Asked Questions
What are SNGX's latest financial results?
Review SNGX's latest balance sheet, income statement, and cash flow to understand its profitability, revenue trends, and financial health. These metrics are essential for evaluating short-term performance and long-term stability.
How has SNGX's revenue and net income changed over time?
Analyzing historical revenue and net income shows growth trends and business performance. Consistent growth indicates operational strength, while declines may signal challenges that investors should consider.
What is SNGX's cash flow situation and liquidity?
Cash flow statements reveal how SNGX generates and uses cash. Strong operating cash flow and sufficient liquidity suggest the company can fund operations, pay dividends, and handle debt effectively.
How does SNGX's financial performance compare to industry peers?
Comparing key metrics like revenue growth, profit margins, and debt levels with competitors helps investors assess whether SNGX is outperforming or lagging within its sector.
Are SNGX's financial statements showing sustainable profitability?
By analyzing margins, ROE, ROIC, and cash generation over multiple periods, investors can evaluate whether SNGX's profits are repeatable and supported by strong fundamentals.